Besides IL-2, L19 was also coupled to IL-12 and tumour necrosis factor (TNF) α, revealing equally promising results in solid metastatic cancers [58,114], in particular for L19-TNF in combination with L19-IL2 [115]. The gene discussed is IL2; the disease is metastatic malignant neoplasm.